News

Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.
Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle ...
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...
Continuous Glucose Monitoring (CGM) devices make it easy to keep your health in check despite seasonal changes, without the ...
Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...
(“Avant” or the“Company”) and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence ...
Two experts discuss why more research is needed before continuous glucose monitors can be used reliably for insulin ...
Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...
Thanh Thuy, an employee at Abbott Vietnam, experienced the company's upgraded mixed reality technology at a blood donation ...
Wearables, or electronic devices worn to collect health-related data, are fast becoming a public health priority. U.S. Health and Human Services Secretary Robert F. Kennedy Jr. told Congress that HHS ...
Abbott and Beta Bionics are collaborating to integrate Abbott’s upcoming dual glucose-ketone sensor with Beta’s iLet Bionic ...
For people with type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...